FDA label
What is Airsupra used for?
Airsupra contains albuterol and budesonide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “AIRSUPRA is indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Airsupra?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Airsupra, aerosol, metered
Indications and Usage, quoted from the label by AstraZeneca Pharmaceuticals LP (NDA214070). Cross-references to other label sections are left out.
AIRSUPRA is indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older.
Source: DailyMed label, set id e60aa9f9-5139-44df-b886-ebddc3c7eb13, version 10, effective September 18, 2025. NDC 0310-9080, one of 1 listing for this product.
Questions
What is Airsupra used for?
The FDA label says: “AIRSUPRA is indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older.”
What drug class is Airsupra?
FDA lists albuterol and budesonide in the Corticosteroid and beta2-Adrenergic Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.